Merck Nixes Some Actions in Vioxx Securities Fraud Battle
By Cara Salvatore · June 19, 2015, 9:33 PM EDT
A New Jersey federal judge partially dismissed seven actions Friday within sprawling securities fraud litigation alleging Merck & Co. misrepresented the heart-attack risk of its arthritis drug Vioxx but said some...
To view the full article, register now.